Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relaps

['lizbeth]

37 treatments sites, and PIK3 pathway blocking.

ClinicalTrials.gov Identifier:
NCT01132664

Purpose This study will assess the safety and efficacy of BKM120 in combination with trastuzumab in patients with relapsing HER2 overexpressing breast cancer who have previously failed trastuzumab.
The study will further assess the safety and preliminary efficacy of BKM120 in combination with trastuzumab and capecitabine in patients with relapsing HER2 overexpressing breast cancer and brain metastases who have previously failed trastuzumab.


http://www.clinicaltrials.gov/ct2/sh...ow_locs=Y#locn